David A. Gewirtz, Ph.D.
Research program member: Developmental Therapeutics
401 College St.
Richmond, VA 23298
Professor, Pharmacology and Toxicology, School of Medicine
PhD, City University of New York, Mt. Sinai (1978)
My research focuses on the capacity of senolytic agents to sensitize tumor cells to chemotherapy and radiation and the mitigation of the toxicity of cancer chemotherapy.
Autophagy,Cancer therapy resistance,DNA damage,Radiotherapy,Senescence